Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000407199

Medchemexpress LLC Mizolastine | 108612-45-9 | 99.8% | 50 MG
SDP

Catalog No. 5000407199
Encompass_Preferred

Mizolastine is an orally active, high-affinity, and specific peripheral histamine H1 receptor antagonist, classified as a second-generation antihistamine. It effectively inhibits the mRNA expression of VEGF165, VEGF120, TNF-α, and KC. Mizolastine is used in studies related to allergic rhinitis and chronic idiopathic urticaria.

  • High-affinity and specific peripheral histamine H1 receptor antagonist
  • Effectively inhibits mRNA expression of VEGF165, VEGF120, TNF-α, and KC
  • Used in studies of allergic rhinitis and chronic idiopathic urticaria
  • Inhibits VEGF, KC, and TNF-α release in mast cells
  • Reduces VEGF165, VEGF120, TNF-α, and KC mRNA expression in mast cells
  • Inhibits 5-LOX AA metabolite leukotriene B4 (LTB4) production
  • Suppresses expression of 5-LOX, cytosolic PLA2 (cPLA2), 5-LOX-activating protein, and LTB4 receptor mRNA

Catalog No. 50-004-07199 Supplier Medchemexpress LLC Supplier No. HYB016450MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Mizolastine is an orally active, high-affinity, and specific peripheral histamine H1 receptor antagonist, classified as a second-generation antihistamine. It effectively inhibits the mRNA expression of VEGF165, VEGF120, TNF-α, and KC. Mizolastine is used in studies related to allergic rhinitis and chronic idiopathic urticaria.

  • High-affinity and specific peripheral histamine H1 receptor antagonist
  • Effectively inhibits mRNA expression of VEGF165, VEGF120, TNF-α, and KC
  • Used in studies of allergic rhinitis and chronic idiopathic urticaria
  • Inhibits VEGF, KC, and TNF-α release in mast cells
  • Reduces VEGF165, VEGF120, TNF-α, and KC mRNA expression in mast cells
  • Inhibits 5-LOX AA metabolite leukotriene B4 (LTB4) production
  • Suppresses expression of 5-LOX, cytosolic PLA2 (cPLA2), 5-LOX-activating protein, and LTB4 receptor mRNA

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.